Company: GCTS
Filing Date: 2025-04-23
Form Type: S-3
Source: 0001104659-25-038025
Chunk: 15

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-04-23
Form: S-3
Chunk 15
---
 on the NYSE;                                        |
| · | the risk that the Business Combination disrupts current plans and operations;                               |
| · | the ability to recognize the anticipated benefits of the Business Combination, which may be affected by,    
 among other things, competition, and the ability of us to grow and manage growth profitably;                |
| · | costs related to the Business Combination; and                                                              |
| · | other risks and uncertainties indicated in this prospectus, including those under “Risk Factors”            
 herein, and other filings that have been made or will be made with the SEC.                                 |

<div align='center'>5</div>

These and other factors that
could cause actual results to differ from those implied by the forward-looking statements in this prospectus are more fully described
in the “Risk Factors” section. The risks described in “Risk Factors” are not exhaustive. These forward-looking
statements are based on information available as of the date of this prospectus, and current expectations, forecasts and assumptions,
and involve a number of judgments, risks and uncertainties. New risk factors emerge from time to time and it is not possible for us to
predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor
or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking
statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements.
We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by law.

<div align='center'>USE OF PROCEEDS</div>

All
of the securities offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their
respective accounts. We could receive up to an aggregate of approximately $103,317,920 if all of the Warrants held by the Selling Securityholders
are exercised for cash. Unless we inform you otherwise in a prospectus supplement or free writing prospectus, we intend to use the net
proceeds from the exercise of such Warrants for general corporate purposes, including, but not limited to, working capital for operations,
capital expenditures and future acquisitions. However, we will only receive such proceeds if and when the holders of the Warrants exercise
the Warrants for cash. The exercise of the Warrants, and any proceeds we